30/07/2026
USAINS Healthcare Honoured to Attend ADVANCE-ID Singapore Delegation Visit to Hospital Pakar USM
Kubang Kerian, 29 July 2026 – USAINS Healthcare was honoured to be invited to attend the official visit of the ADVANCE-ID, National University of Singapore (NUS) delegation to Hospital Pakar Universiti Sains Malaysia (HPUSM). The visit was held in conjunction with discussions on the implementation of the Optimising TREATment for Severe Gram-Negative Bacterial Infections (TREAT-GNB) clinical trial.
The ADVANCE-ID delegation was welcomed by Professor Dr. Mohd Imran Bin Yusof, Deputy Director of Operations, Hospital Pakar USM, representing the Director of Hospital Pakar USM. The event was also attended by Associate Professor Dr. Mohd Zulfakar, who serves as the Principal Investigator (PI), representatives from the Department of Medicine, Department of Medical Microbiology, Clinical Trial Unit, Intensive Care Unit (ICU), Research Pharmacy Unit, as well as USAINS Healthcare as a strategic partner in the clinical trial initiative.
The visit served as a platform to discuss the progress of the TREAT-GNB study, including patient screening and recruitment processes, while providing the delegation with an opportunity to tour the hospital's research facilities and clinical services that support the implementation of international clinical trials. The ADVANCE-ID delegation was led by Dr. Mo Yin, Co-Director of ADVANCE-ID, accompanied by Dr. Abi Manesh, Visiting Associate Professor, Ms. Ong May Gee, Project Manager for TREAT-GNB, and Ms. Nur Kalimah Husna Binte Mohamed Nazri, Study Monitor of ADVANCE-ID.
As a strategic partner in this collaboration, USAINS Healthcare plays a key role in facilitating and coordinating the overall implementation of the clinical trial partnership. Through this collaboration, USAINS Healthcare remains committed to expanding international research collaborations, enhancing Malaysia's clinical research capabilities, and supporting the development of evidence-based treatments that benefit patients and the wider medical community.
During the visit, the delegation toured the Clinical Trial Unit, Medical Microbiology Laboratory, Intensive Care Unit (ICU), relevant hospital wards, and the Research Pharmacy Unit, gaining first-hand insight into Hospital Pakar USM's readiness and capabilities in conducting internationally recognised clinical research.
The visit reflects the shared commitment of Hospital Pakar USM and USAINS Healthcare to strengthening global research collaborations and further establishing Hospital Pakar USM as a regional centre of excellence in clinical trials and medical research.
USAINS Healthcare welcomes collaborations in clinical trials, medical research, training, and healthcare development. For partnership enquiries, please contact us at +609-767 3801 or 019-696 3080